Of note, a significant difference between MS and GBS patients was present for Pro-BDNF: MS samples showed Pro-BDNF levels in line with those of control subjects, whereas a significant increase was measured in GBS patients. The gene discussed is BDNF; the disease is myeloid sarcoma.